Two novel 14-epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2673-2679

  Verlinden, Lieve ^a   Verstuyf, Annemieke ^a   Van Camp, Mark ^a   Marcelis, Suzanne ^a   Sabbe, Katrien ^b   Zhao, Xu Yang ^b   De Clercq, Pierre ^b   Vandewalle, Maurits ^b   Bouillon, Roger ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c LEGENDO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

19 NOR 14 EPI 23 YNECALCITRIOL; 19 NOR 14,20 BISEPI 23 YNECALCITRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CYCLIN C; CYCLIN D1; CYCLINE; KS 532; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CALCINOSIS;

ALKYNES; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CHOLECALCIFEROL; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; G1 PHASE; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CALCITRIOL; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN;

EID: 0034658124     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 3 analogues and tamoxifen. Cancer Res., 54: 5711-5717, 1994.
2. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol. Cell. Endocrinol., 142: 57-65, 1998.
3. 3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood, 93: 2721-2729, 1999.
4. 3 analog, EB 1089. Endocrinology, 139: 2102-2110, 1998.
5. Bouillon, R., Okamura, W. H., and Norman, A. W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16: 200-257, 1995.
6. Bouillon, R., Allewaert, K., van Leeuwen, J. P. T. M., Tan, B. K., Xiang, D. Z., De Clercq, P., Vandewalle, M., Pols, H. A. P., Bos, M. P., and van Baelen, H. Structure function analysis of vitamin D analogs with C-ring modifications. J. Biol. Chem., 267: 3044-3051, 1992.
7. 3 and related analogues. J. Org. Chem., 57: 3214-3217, 1992.
8. 3. Bioorg. Med. Chem. Lett., 3: 1855-1858, 1993.
9. 3 and its analogs. J. Bone Miner. Res., 9: 1277-1288, 1994.
10. 3: synthesis, isomerisation to provitamins, and biological studies. Med. Chem., 37: 2387-2393, 1994.
11. 3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk. Res., 18: 453-463, 1994.
12. Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., and Juratka, P. W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res., 13: 325-349, 1998.
13. McElwain, M., Modzelewski, R. A., Yu, W. D., Russell, D. M., and Johnson, C. S. Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma. Am. J. Otolaryngol., 18: 293-298, 1997.
14. Verstuyf, A., Verlinden, L., Van Baelen, H., Sabbe, K., D'Hallewyn, C., De Clercq, P., Vandewalle, M., and Bouillon, R. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J. Bone Miner. Res., 13: 549-558, 1998.
15. Grana, X., Garriga, J., and Mayol, X. Role of the retinoblastoma protein family. pRB, p107 and p130 in the negative control of cell growth. Oncogene, 17: 3365-3383, 1998.
16. Lania, L., Majello, B., and Napolitano, G. Transcriptional control by cell-cycle regulators: a review. J. Cell. Phys., 179: 134-141, 1999.
17. 3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int. J. Cancer. 81: 730-733, 1999.
18. 3 receptor gene expression in cultured cells by serum and growth factors. J. Bone Miner. Res., 6: 1099-1107, 1991.
19. Musgrove, E. A., Lee, S. L., Buckley, M. F., and Sutherland, R. L. Cyclin D1 induction in breast cancer cells shortens G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
20. Zhou, Q., Stetler-Stevenson, M., and Steeg, P. S. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene, 15: 107-115, 1997.
21. Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. J. A. M. Cdk-independent activation of estrogen receptor by cyclin D1. Cell, 88: 405-415, 1997.
22. Leopold, P., and O'Farrell, P. H. An evolutionary conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins. Cell, 66: 1207-1216, 1991.
23. Rickert, P., Corden, J. L., and Lees, E. Cyclin C/cdk8 and cyclin H/cdk7/p36 are biochemically distinct CTD kinases. Oncogene, 18: 1093-1102, 1999.
24. Shao, Z., and Robhins, P. D. Differential regulation of E2F and Sp1-mediated transcription by G1 cyclins. Oncogene, 10: 221-228, 1995.
25. Takeyama, K., Masuhiro, Y., Fuse, H., Endoh, H., Murayama, A., Kitanaka, S., Suzawa, M., Yanagisawa, J., and Kato, S. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol. Cell. Biol., 19: 1049-1055, 1999.
26. Wat1/Cip1 in vitro and in vivo. Cancer Res., 59: 2644-2649, 1999.
27. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
28. 3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp. Cell Res., 235: 210-217, 1997.